Serotonergic attenuation of the reinforcing and neurochemical effects of cocaine in squirrel monkeys.
about
Nonhuman primate positron emission tomography neuroimaging in drug abuse researchDopamine transporter-related effects of modafinil in rhesus monkeys.Neuroimaging and drug taking in primatesDual dopamine/serotonin releasers: potential treatment agents for stimulant addictionDual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictionsBehavioral and neurochemical effects of amphetamine analogs that release monoamines in the squirrel monkeySelective suppression of cocaine- versus food-maintained responding by monoamine releasers in rhesus monkeys: benzylpiperazine, (+)phenmetrazine, and 4-benzylpiperidineFaster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeysSerotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorderBalance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugsNonhuman primate neuroimaging and cocaine medication developmentMonoamine transporter inhibitors and substrates as treatments for stimulant abuseNeurobiological changes mediating the effects of chronic fluoxetine on cocaine use.Brain imaging in nonhuman primates: insights into drug addiction.Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction.Effects of histamine H(3) receptor activation on the behavioral-stimulant effects of methamphetamine and cocaine in mice and squirrel monkeys.Attenuation of cocaine-induced reinstatement of drug seeking in squirrel monkeys: kappa opioid and serotonergic mechanismsSerotonin at the nexus of impulsivity and cue reactivity in cocaine addiction.Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study.The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens.Serotonin (5HT), fluoxetine, imipramine and dopamine target distinct 5HT receptor signaling to modulate Caenorhabditis elegans egg-laying behavior.Role of serotonin in cocaine effects in mice with reduced dopamine transporter function.Preclinical evaluation of the abuse potential of the analgesic bicifadine.Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications.Role of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates.Behavioral and neurochemical effects of cocaine and diphenhydramine combinations in rhesus monkeys.The cystine-glutamate transporter enhancer N-acetyl-L-cysteine attenuates cocaine-induced changes in striatal dopamine but not self-administration in squirrel monkeys.Agonist replacement therapy for cocaine dependence: a translational review.Attenuation of cocaine-induced reinstatement of drug seeking in squirrel monkeys by direct and indirect activation of 5-HT2C receptors.Effects of serotonin 2C receptor agonists on the behavioral and neurochemical effects of cocaine in squirrel monkeys.Differential modulation of cocaine's discriminative cue by repeated and variable stress exposure: relation to monoamine transporter levelsEffects of cocaine and MDMA self-administration on serotonin transporter availability in monkeys.Abuse-Related Neurochemical Effects of Para-Substituted Methcathinone Analogs in Rats: Microdialysis Studies of Nucleus Accumbens Dopamine and Serotonin.Review. Positron emission tomography imaging studies of dopamine receptors in primate models of addictionEvaluation of the "Pipeline" for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research.Lack of cocaine self-administration in mice expressing a cocaine-insensitive dopamine transporter.In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery.Effects of the serotonin 2C receptor agonist WAY163909 on the abuse-related effects and mesolimbic dopamine neurochemistry induced by abused stimulants in rhesus monkeys.N-Alkylated Analogs of 4-Methylamphetamine (4-MA) Differentially Affect Monoamine Transporters and Abuse Liability.Repeated MDMA administration increases MDMA-produced locomotor activity and facilitates the acquisition of MDMA self-administration: role of dopamine D2 receptor mechanisms.
P2860
Q24607038-E1493824-2249-46B3-B485-4705E2AFD13FQ24608414-5E894ED5-3F03-4C37-99C6-8E2FC68E71AAQ24631230-6D43F615-4431-40A9-9679-E177EC2CF84BQ24641896-CFEF1B67-1AA0-4E80-BFCF-05EAD01D0CE7Q24647786-1A4A4A46-7AB8-40DC-8318-E9A51F62A100Q24651855-B0C39FF3-A711-462C-BC94-062F0F97C952Q24657405-6FB68475-7F35-4A59-827D-12E262CDD252Q24685831-18E146A6-0129-4DDA-AB68-02DDC68A3DEEQ27015917-281309B4-F83B-499D-8202-B5FF81790E53Q28274119-3D24EABA-988E-4B0E-9368-3C53A86869BCQ28304167-0B2E4E7F-C019-4CCE-AA44-89E836BC1FDEQ30413718-33CBDC37-A329-4A44-B2F6-629990B80071Q30453028-97B5E7CE-548A-4DCF-B5D2-EF7832661838Q31141730-42B0F170-9A4B-4AFB-A271-2EC0A9E9FB7DQ33383360-D5BE67E6-D0BA-4873-A4D8-13B183D9539FQ33709951-FF2B3B4A-04BA-4BD9-B64C-C67E1200501AQ33835362-69B6C3AE-8FAE-437C-BCDC-AAFA6D46D78BQ33874819-5042F196-7280-42A5-89E5-17AB7942F02BQ33998159-C954DC10-0D55-4FB5-9295-43DB3B3ED847Q34546304-478364F3-F80F-4D56-8211-5FBF42C84858Q34572365-86CAC34F-F74F-4FC8-8E76-2D72164ECECEQ35122959-BA072DDC-EF2A-4099-A664-2AF5ACC9F5B7Q35453895-B528BBE7-EF02-4D36-8515-5B01BC4911E8Q35576598-4529D72B-3CF4-4D63-A2E2-9D47C3F24B1BQ35590703-A7B28572-A593-4D10-BF24-5AFC9E21F43CQ35599708-1B41D792-B832-4416-9B41-CF0BA50C7A9AQ35785319-81FE32BF-1F0F-47FB-82FB-596051C06D03Q35799846-47800EDF-2A27-4B6C-B735-E3D1F1A3D2A2Q35889437-AAAED2B8-B61D-4107-A2BC-466781D9C2D9Q35913179-DA00F50D-7775-438D-BCF2-5AB1271D4CC0Q36024364-59034964-7F30-4ED8-A6D3-488BBEC2948AQ36312733-4F6BEF7E-FDE7-49A6-9917-1E73222AE886Q36432300-79C5C2F2-A54B-4439-A7FA-7D7B147181C4Q37024151-2ABD3B42-1D2E-41C6-9183-4BD124748EABQ37062538-C3D95C05-E1AC-46AA-A2AA-77425361292CQ37397255-ECC21C73-4A29-45EE-98E5-B2C0ED8F2E31Q37870701-7C1C76FA-D5BE-4496-A841-D545EC601B23Q38741661-BB97D7CD-44E1-4CD2-923E-545FB3A70819Q38771797-71640EB6-4AB4-49D4-B240-67C21E8FAABFQ38966523-8AE93341-F62D-4543-BC02-1E0DA6C1ED91
P2860
Serotonergic attenuation of the reinforcing and neurochemical effects of cocaine in squirrel monkeys.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Serotonergic attenuation of th ...... f cocaine in squirrel monkeys.
@ast
Serotonergic attenuation of th ...... f cocaine in squirrel monkeys.
@en
type
label
Serotonergic attenuation of th ...... f cocaine in squirrel monkeys.
@ast
Serotonergic attenuation of th ...... f cocaine in squirrel monkeys.
@en
prefLabel
Serotonergic attenuation of th ...... f cocaine in squirrel monkeys.
@ast
Serotonergic attenuation of th ...... f cocaine in squirrel monkeys.
@en
P2093
P356
P1476
Serotonergic attenuation of th ...... f cocaine in squirrel monkeys.
@en
P2093
Brett C Ginsburg
Leonard L Howell
Paul W Czoty
P304
P356
10.1124/JPET.300.3.831
P407
P577
2002-03-01T00:00:00Z